Pfizer Inc. (PFE) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Pfizer Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Short-term borrowings, including current portion of long-term debt | |
|
|
|
|
|
Accounts payable | |
|
|
|
|
|
Dividends payable | |
|
|
|
|
|
Income taxes payable | |
|
|
|
|
|
Accrued compensation and related items | |
|
|
|
|
|
Other current liabilities | |
|
|
|
|
|
Current liabilities | % |
% |
% |
% |
% |
|
Long-term debt, excluding current portion | |
|
|
|
|
|
Pension benefit obligations | |
|
|
|
|
|
Postretirement benefit obligations | |
|
|
|
|
|
Noncurrent deferred tax liabilities | |
|
|
|
|
|
Other taxes payable | |
|
|
|
|
|
Other noncurrent liabilities | |
|
|
|
|
|
Noncurrent liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Preferred stock, without par value, at stated value | |
|
|
|
|
|
Common stock, $0.05 par value | |
|
|
|
|
|
Additional paid-in capital | |
|
|
|
|
|
Employee benefit trusts | |
|
|
|
|
|
Treasury stock, shares at cost | |
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
Accumulated other comprehensive income (loss) | |
|
|
|
|
|
Pfizer Inc. shareholders’ equity | % |
% |
% |
% |
% |
|
Equity attributable to noncontrolling interests | |
|
|
|
|
|
Total shareholders’ equity | % |
% |
% |
% |
% |
|
Total liabilities and shareholders’ equity | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center